More about Genmab

Genmab is a global player in the development of new cancer drugs and has been an important part of the very strong cluster of cancer research at Utrecht Science Park for 25 years. Genmab is working on the development of therapeutic antibodies, especially for the treatment of cancer. These antibodies are unique due to their special specificity for tumor cells and their great effectiveness in destroying them.

Genmab R&D Center Utrecht Science Park (photocredits Sebastiaan Knot)